DKD	diabetic kidney disease
CKD	chronic kidney disease
CVD	cardiovascular disease
T2D	type 2 diabetes
TGF-β	transforming growth factor-β
ECM	extracellular matrix
NF-κB	nuclear factor-κB
eGFR	estimated glomerular filtration rate
GLP-1	glucagon-like peptide 1
GDF 15	growth/differentiation factor 15
LKB-1	liver kinase B-1
AMPK	AMP-activated kinase
OCT	organic cationic transporter
MATE	multidrug and toxin extrusion
mTOR	mammalian target of rapamycin
FAO	fatty acid oxidation
UUO	unilateral urethral obstruction
ACC	acetyl-CoA carboxylase
MALA	metformin-associated lactic acidosis
CAVNVAS	Canagliflozin Cardiovascular Assessment Study Program
LEADER	Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
SUSTAIN-6	Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes
REWIND	Researching Cardiovascular Events with a Weekly Incretin in Diabetes